Total Payments
$56,170
2024 Payments
$26,515
Companies
17
Transactions
127
Medicare Patients
1,698
Medicare Billing
$126,844
Payment Breakdown by Category
Other$33,688 (60.0%)
Research$11,750 (20.9%)
Travel$4,534 (8.1%)
Food & Beverage$3,998 (7.1%)
Consulting$2,200 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $31,888 | 14 | 56.8% |
| Unspecified | $11,750 | 2 | 20.9% |
| Travel and Lodging | $4,534 | 24 | 8.1% |
| Food and Beverage | $3,998 | 83 | 7.1% |
| Consulting Fee | $2,200 | 3 | 3.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,800 | 1 | 3.2% |
Payments by Type
General
$44,420
125 transactions
Research
$11,750
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $43,524 | 60 | $0 (2024) |
| Bausch Health US, LLC | $6,750 | 1 | $0 (2021) |
| Tarsus Pharmaceuticals, Inc. | $2,775 | 11 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $1,276 | 11 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $495.74 | 9 | $0 (2021) |
| Alcon Vision LLC | $448.73 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $192.11 | 3 | $0 (2023) |
| Oyster Point Pharma, Inc. | $150.01 | 1 | $0 (2022) |
| TissueTech, Inc. | $140.22 | 6 | $0 (2018) |
| Harrow Eye, LLC | $115.77 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,515 | 54 | Bausch & Lomb Americas Inc. ($23,485) |
| 2023 | $19,170 | 21 | Bausch & Lomb Americas Inc. ($18,849) |
| 2022 | $1,477 | 12 | Bausch & Lomb Americas Inc. ($1,190) |
| 2021 | $7,049 | 9 | Bausch Health US, LLC ($6,750) |
| 2020 | $61.81 | 1 | Alcon Vision LLC ($61.81) |
| 2019 | $242.50 | 5 | Bausch & Lomb, a division of Bausch Health US, LLC ($211.24) |
| 2018 | $316.81 | 11 | Bausch & Lomb, a division of Bausch Health US, LLC ($154.22) |
| 2017 | $1,337 | 14 | Valeant Pharmaceuticals North America LLC ($1,276) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/03/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $114.57 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $625.00 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | Alcon Vision LLC | Precision 7 (Device) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $102.07 | General |
| 10/10/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $13.70 | General |
| 10/09/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/08/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $710.95 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $168.37 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $132.72 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $58.29 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $50.49 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $31.88 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $24.87 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $23.51 | General |
| 08/28/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 07/30/2024 | Bausch & Lomb Americas Inc. | BLINK NUTRITEARS (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $250.00 | General |
| Category: Ophthalmology | ||||||
| 07/30/2024 | Bausch & Lomb Americas Inc. | BLINK NUTRITEARS (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $250.00 | General |
| Category: Ophthalmology | ||||||
| 07/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $36.82 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Ophthalmology | ||||||
| 06/08/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $322.94 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Retrospective Assessment of the Routine Use of Zylet (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension) for the treatment of ocular infections and inflammation | Bausch Health US, LLC | $6,750 | 1 |
| A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution, Used Two Times Daily in Healthy | Bausch & Lomb Americas Inc. | $5,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 359 | 415 | $56,428 | $25,633 |
| 2022 | 9 | 418 | 499 | $66,887 | $30,577 |
| 2021 | 8 | 435 | 570 | $72,025 | $34,180 |
| 2020 | 10 | 486 | 626 | $76,279 | $36,453 |
Total Patients
1,698
Total Services
2,110
Medicare Billing
$126,844
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 97 | 97 | $14,453 | $7,462 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 64 | $9,600 | $5,265 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 72 | $7,128 | $4,549 | 63.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 30 | 30 | $5,370 | $2,745 | 51.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 16 | 24 | $6,000 | $1,937 | 32.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 35 | 45 | $5,535 | $1,765 | 31.9% |
| 92250 | Photography of the retina | Office | 2023 | 38 | 38 | $3,572 | $1,020 | 28.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 29 | 33 | $3,498 | $682.02 | 19.5% |
| 92134 | Imaging of retina | Office | 2023 | 11 | 12 | $1,272 | $207.64 | 16.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 90 | 91 | $13,559 | $7,075 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 122 | $11,374 | $6,728 | 59.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 59 | 59 | $10,561 | $5,558 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 40 | $6,000 | $3,717 | 62.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2022 | 26 | 37 | $9,202 | $3,049 | 33.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 44 | 51 | $6,273 | $1,970 | 31.4% |
| 92250 | Photography of the retina | Office | 2022 | 44 | 48 | $4,512 | $1,278 | 28.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 30 | 35 | $3,710 | $797.56 | 21.5% |
| 92134 | Imaging of retina | Office | 2022 | 14 | 16 | $1,696 | $404.85 | 23.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 189 | $16,632 | $11,762 | 70.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 101 | 103 | $15,347 | $7,792 | 50.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 71 | 71 | $12,709 | $6,606 | 52.0% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 56 | 71 | $8,733 | $2,843 | 32.6% |
| 66984 | Removal of cataract with insertion of lens, simple | Office | 2021 | 22 | 33 | $8,118 | $2,669 | 32.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 40 | 49 | $5,194 | $1,138 | 21.9% |
| 92250 | Photography of the retina | Office | 2021 | 29 | 36 | $3,384 | $902.64 | 26.7% |
About Dr. Patrick Vollmer, O.D
Dr. Patrick Vollmer, O.D is a Optometrist healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1952784928.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Vollmer, O.D has received a total of $56,170 in payments from pharmaceutical and medical device companies, with $26,515 received in 2024. These payments were reported across 127 transactions from 17 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a medical education program" ($31,888).
As a Medicare-enrolled provider, Vollmer has provided services to 1,698 Medicare beneficiaries, totaling 2,110 services with total Medicare billing of $126,844. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Columbia, SC
- Active Since 07/08/2015
- Last Updated 07/08/2015
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952784928
Products in Payments
- MIEBO (Drug) $36,409
- ZYLET (Drug) $6,750
- XDEMVY (Drug) $2,347
- ULTRA (Device) $1,295
- BLINK NUTRITEARS (Drug) $500.00
- DOCTORS ALLERGY FORMULA (Device) $259.81
- XIIDRA (Drug) $230.17
- LOTEMAX SM (Drug) $166.00
- Precision 1 (Device) $165.57
- TYRVAYA (Drug) $150.01
- Prokera (Device) $140.22
- LOTEMAX (Drug) $128.50
- PROLENSA (Drug) $124.06
- ALREX (Drug) $120.00
- VYZULTA (Drug) $100.15
- BIOTRUE ONE DAY (Device) $98.34
- TEPEZZA (Drug) $94.22
- DAILIES (Device) $80.34
- DAILIES TOTAL1 (Device) $75.02
- TOTAL30 (Device) $62.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Columbia
Dr. Heather Webster, O.d, O.D
Optometrist — Payments: $105,346
Optometrist $105,346
Dr. Jennifer Drake, Od, OD
Optometrist — Payments: $75,052
Optometrist $75,052
Dr. Bradley Powers, O.d, O.D
Optometrist — Payments: $9,355
Optometrist $9,355
Wayne Cannon, O.d, O.D
Optometrist — Payments: $7,059
Optometrist $7,059
Dr. Christina Generie, Od, OD
Optometrist — Payments: $6,838
Optometrist $6,838
Dr. Dorothy Park, Od, OD
Optometrist — Payments: $6,286
Optometrist $6,286